Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy
technology science top
(MENAFN - ALA Group) –Agreement will enable selection of Kahimmune–s first companion neoantigen therapy candidate against colorectal cancer and pancreatic cancer, with financial support from ... 2026-04-28 03:20:25
Latest News and Headlines
(MENAFN - ALA Group) –Agreement will enable selection of Kahimmune–s first companion neoantigen therapy candidate against colorectal cancer ...
News